Loading cancer entity…
Loading cancer entity…
Clinical trials
102 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04163419 | Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis | unknown | Phase 2 | 9 | Massachusetts General HospitalOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT04801953 | Nimodipine in Vestibular Schwanommas | unknown | Phase 2 | 30 | Medical University of ViennaOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT03393689 |
| RGD PET/MRI in Sporadic Vestibular Schwannoma |
| unknown |
| Phase 2 |
| 40 |
| Rigshospitalet, DenmarkOTHER |
| 1 |
| Jan 10, 2018 |
| clinicaltrials |
Data updated 23 days agoSource updated Mar 13, 2024source: clinicaltrials